Trials / Completed
CompletedNCT02814994
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
Respiratory System Compliance Guided Tidal Volume in Moderate to Severe ARDS Patients: A Multicenter Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Acute Respiratory Distress Syndrome (ARDS) is one of common clinical critically diseases. In the United States, the incidence of ARDS reaches 31%, which is one of the main causes of death in patients. There is no unified treatment process for ARDS currently and the treatment measures are not yet standardized, so the standardization of ARDS treatment processes is needed to reduce mortality in patients. Following the evidence-based medicine principles and six-step treatment standards of ARDS, this study uses the method of multi-center randomized controlled clinical trials to evaluate the standardized treatment process of ARDS, which provides the basis for the standardized treatment of ARDS.
Detailed description
From September 1st 2012 to September 30th 2014, all ARDS patients admitted to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | tidal volume guided by respiratory system compliance | ventilated with tidal volume guided by respiratory system compliance |
| BEHAVIORAL | low tidal volume | ventilation ventilated with low tidal volume |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-05-01
- Completion
- 2014-06-01
- First posted
- 2016-06-28
- Last updated
- 2016-06-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02814994. Inclusion in this directory is not an endorsement.